Tissue factor and PAR2 signaling in the tumor microenvironment - Wikidata - thesis-toulmin - TriplyDB

Tissue factor and PAR2 signaling in the tumor microenvironment

Tissue factor and PAR2 signaling in the tumor microenvironment

http://www.wikidata.org/entity/Q33592102

about

MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells Endometriosis, angiogenesis and tissue factor The wound healing, chronic fibrosis, and cancer progression triad Initial steps of metastasis: cell invasion and endothelial transmigration Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems--a chemical biology approach for thrombosis-related side effects.Tissue Factor promotes breast cancer stem cell activity in vitro.Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.Platelets and cancer: a casual or causal relationship: revisited.Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.Tissue factor-dependent chemokine production aggravates experimental colitis.Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.The Interface between Inflammation and Coagulation in Cardiovascular Disease.HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering.Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling Tissue factor in cancer progression and angiogenesis.Thrombomodulin modulates cell migration in human melanoma cell lines.Tissue factor: past, present, and future The platelet contribution to cancer progression.Tissue factor and cell signalling in cancer progression and thrombosis.Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways.Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas.Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.Molecular Approaches To Target GPCRs in Cancer Therapy.The Role of Hypoxia in Glioblastoma Invasion.YKL-40, a chitinase-like protein at the intersection of inflammation and remodeling.

P2860

Q24598503-83D48DAA-A3FA-46A2-A6B8-ED2D803BBE42 Q27013803-59CC2C03-49EE-498B-AAD1-6525A3D73F7E Q27014616-063FE49D-0B22-48CC-B8EF-530C3D0058CD Q28238397-A6FA699E-E4D9-48F5-B2B2-7150E5B38021 Q30883298-FC62DD56-1898-4DAC-BA5D-EB187BEF1829 Q33688466-27965480-E2A7-4330-A096-08E5976EE77E Q33720303-D0218D07-2502-4CEF-AA97-FE7B9E36E885 Q33759372-E021CEF8-8EED-47F3-AF63-77FBA40DF9FD Q34294719-94B6FA01-6A66-4BE1-AE68-C4A5D0A1A568 Q34541646-4A64F771-FB0C-4161-B38B-7C18C74EA03F Q34893956-782BCA4A-E5F7-4551-8D95-2DC83052CDE6 Q35055560-38DA0663-16E6-47DC-8BDE-9F9C0BDD0E66 Q35287011-CFEA4186-9F73-451A-A488-3B14849B866D Q35605751-30C1FAAA-B222-45A3-B111-C16BACB03F80 Q35766780-56F9C806-7345-4D89-8BE9-2DF8C2C28DA5 Q35821321-A83079AB-5244-4BBB-91E4-2FC7D7ACBCCE Q36061902-E43DF92E-C6F4-4EDD-B767-3921044D65EB Q36322931-8B276E9D-B41E-42D5-AA16-F2182A613B54 Q36518235-B08EA7AC-EB34-4CCE-8714-7EF9A1D76C5D Q36710897-A473491F-A2BD-4491-B294-641D72D7361D Q37193598-29E6EC4A-36D9-4452-A83E-A88D1216B865 Q37308155-701463F1-C440-490D-BCFF-44DBE16AA2F0 Q37416926-8AB0E649-3782-4209-A288-AC3D18C1DB73 Q37634815-63B240E1-6876-42CF-8A52-8EE0D0906E98 Q37805788-4A8C0F89-4208-4F5D-B9DB-7C1FF33058B9 Q37903955-1821A5D9-857E-4485-9371-638E60A607F4 Q38718464-6F53B21D-1ED5-47C6-9C88-B310B28082C4 Q38756901-C68753F4-60B3-4483-8062-52498F07C479 Q38758445-4F26CAAD-DF76-4B3A-AE01-EE1BDC5D399D Q38836736-D236D865-3CEC-4216-8EB5-910A74E437A8 Q39160971-C08B01D6-DA7F-44B2-8684-A7424405BB45 Q39227575-16D41762-FB78-4BF3-B71B-5CEE021EF46E Q39241236-26BBDE75-C5CD-4B5A-9F7D-3DD73994E784 Q39533486-C3B62D96-2DE3-4C36-AE74-572EEF0C984F Q41505438-F4AE4EFC-6C7D-4889-95EF-B11C48B946AB Q41709078-A269110A-5067-4A82-8317-D4075CDB69B7 Q43963683-86D1EE2C-D9CC-46A1-9FCC-879AB3EA8476 Q46850333-E046A4D7-F365-4096-96EC-B06F7957FBC9 Q47374256-C029A718-BDA7-4D45-9C0C-AF8D0C42BABB Q50231818-5A4A8D8D-7340-41E0-991E-AA4AFC81A87B

P2860

Tissue factor and PAR2 signaling in the tumor microenvironment

http://www.wikidata.org/entity/Q33592102

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Tissue factor and PAR2 signaling in the tumor microenvironment

@ast

Tissue factor and PAR2 signaling in the tumor microenvironment

@en

type

label

Tissue factor and PAR2 signaling in the tumor microenvironment

@ast

Tissue factor and PAR2 signaling in the tumor microenvironment

@en

prefLabel

Tissue factor and PAR2 signaling in the tumor microenvironment

@ast

Tissue factor and PAR2 signaling in the tumor microenvironment

@en

P1433

Q33592102-CF07CC0C-D8BF-43E4-A714-E681BF4689B4

P1476

Q33592102-650F967A-02A5-4B58-B147-A0889DA7587A

P2093

Q33592102-7628B892-9372-4FE6-B58A-D9DAD2E49E91

Q33592102-9CFC3778-0801-4C6B-B267-FD982EDDC3A8

P2860

Q33592102-0E2BD550-DA9D-49CD-A207-3920C78B9335

Q33592102-10BC1599-9421-4EEE-81E3-0FCCC2E67456

Q33592102-11987430-0CFE-4381-B367-F79C4E1C5422

Q33592102-130CAD22-0D7D-4734-AB88-2CEAE09A097C

Q33592102-137C1B4C-D4B9-4B6C-90FA-7DD9E9AD224C

Q33592102-16A74482-9266-47A6-8D9B-791BC543985A

Q33592102-1B079061-DC27-4F8C-A31D-8B4F929722E6

Q33592102-219BEDF1-E4A2-4DF5-9758-F8564B4FE7FC

Q33592102-25921993-19D6-4005-8C77-5C3D4198CCC6

Q33592102-3114536A-FFB4-4935-9455-8EB3E8E5783C

P304

Q33592102-6872177C-5BFA-46EA-A13B-EAEFD45347FE

P31

Q33592102-40451E88-8BE1-490F-A396-A094298D405E

P356

Q33592102-1BAEEA8F-4E1F-4384-A466-90317A57D010

P407

Q33592102-036D65FC-B278-4B71-870E-C20B8EF123AB

P433

Q33592102-93DB951A-4B5D-4353-B03C-15951D2225A9

P478

Q33592102-14E2DEB6-4BEC-4421-9A39-C6DF7B0F90D4

P577

Q33592102-A5367D17-54DE-4C84-83B3-970A0110C8B2

P698

Q33592102-6BF71A96-C939-4367-9103-6E99F12E759B

P932

Q33592102-8D4E3BE1-7453-4CAA-B401-0B7FFE0C716C

P356

ATVBAHA.108.177428

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Tissue factor and PAR2 signaling in the tumor microenvironment

@en

P2093

Florence Schaffner

http://www.w3.org/2001/XMLSchema#string

Wolfram Ruf

http://www.w3.org/2001/XMLSchema#string

P2860

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2

Thrombin receptor overexpression in malignant and physiological invasion processes

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

Trousseau's syndrome: multiple definitions and multiple mechanisms

A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors

Thrombin signalling and protease-activated receptors

Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

P304

1999-2004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.108.177428

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19661489

http://www.w3.org/2001/XMLSchema#string

P932

2806842

http://www.w3.org/2001/XMLSchema#string